Literature DB >> 9052504

Pancreatic fluid hypersecretion in rats after acute pancreatitis.

L Czakó1, M Yamamoto, M Otsuki.   

Abstract

Pancreatic exocrine function was examined in rats during the early stage of acute pancreatitis induced by four subcutaneous injections of 20 micrograms/kg body weight of cerulein at hourly intervals. Basal pancreatic fluid secretion at 6 hr after the first of four cerulein injections was significantly elevated (27.6 +/- 3.7 vs 17.4 +/- 2.1 microliters/30 min in control, P < 0.01) and further increased with time, reaching the peak level at 24 hr (105.1 +/- 4.6 microliters/30 min). Intravenous infusion of loxiglumide (50 mg/kg body wt/hr), atropine (100 micrograms/kg body wt/hr), or anti-secretin serum did not modify the fluid hypersecretion observed at 24 hr after induction of acute pancreatitis. Loxiglumide, when given 30 min before the first cerulein injection, markedly reduced fluid secretion, but could not inhibit the fluid hypersecretion when applied after the last cerulein injection. Leakage of Evans blue dye into pancreatic juice was slightly but significantly increased in postpancreatitic rats compared with that in the control rats (1.30 +/- 0.17 vs 0.75 +/- 0.08 micrograms/ml, P < 0.01), whereas that in the pancreas was not different from the control rats. In vivo labeling with 5-bromo-2'-deoxyuridine showed active proliferation of acinar and ductular cells at 6 hr. In addition, the fluid was rich in chloride (137.1 +/- 2.5 at 24 hr vs 92.4 +/- 3.3 meq/liter in control, P < 0.01) but poor in bicarbonate concentration (39.0 +/- 2.0 at 24 hr vs 46.5 +/- 1.9 mmol/liter in control, P < 0.01), indicating acinar cell secretion. These results indicate that pancreatic fluid secretion during the early stage of acute pancreatitis induced by supramaximal doses of cerulein was markedly increased not by CCK-, secretin-, or cholinergic-dependent mechanisms but probably by acinar cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052504     DOI: 10.1023/a:1018893230319

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.

Authors:  M Niederau; C Niederau; G Strohmeyer; J H Grendell
Journal:  Am J Physiol       Date:  1989-01

2.  Simple method for quantitation of enhanced vascular permeability.

Authors:  K Udaka; Y Takeuchi; H Z Movat
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

3.  A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions.

Authors:  M Ceska; K Birath; B Brown
Journal:  Clin Chim Acta       Date:  1969-12       Impact factor: 3.786

4.  Effects of a new benzodiazepine derivative cholecystokinin receptor antagonist FK480 on pancreatic exocrine secretion in anesthetized rats.

Authors:  I Tachibana; M Otsuki
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

5.  Caerulein-induced acute pancreatitis in the rat. Pancreatic secretory response to cholecystokinin.

Authors:  J I San Román; I De Dios; M A Manso; J J Calvo; M A López
Journal:  Arch Int Physiol Biochim       Date:  1990-10

6.  Effects of tetraprenylacetone on pancreatic exocrine secretion and acute pancreatitis in two experimental models in rats.

Authors:  I Tachibana; N Watanabe; H Shirohara; T Akiyama; S Nanano; M Otsuki
Journal:  Int J Pancreatol       Date:  1995-04

7.  Effects of cholecystokinin on cytosolic calcium in pancreatic duct segments and ductal cells.

Authors:  J P Smith; R V Yelamarty; S T Kramer; J Y Cheung
Journal:  Am J Physiol       Date:  1993-06

8.  Effect of atropine on rat basal pancreatic secretion during return or diversion of bile-pancreatic juice.

Authors:  K Miyasaka; G M Green
Journal:  Proc Soc Exp Biol Med       Date:  1983-11

9.  Soybean trypsin inhibitor and cerulein accelerate recovery of cerulein-induced pancreatitis in rats.

Authors:  G Jurkowska; G Grondin; S Massé; J Morisset
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

10.  Alteration of membrane fusion as a cause of acute pancreatitis in the rat.

Authors:  G Adler; G Rohr; H F Kern
Journal:  Dig Dis Sci       Date:  1982-11       Impact factor: 3.199

View more
  6 in total

Review 1.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 2.  The acinar-ductal tango in the pathogenesis of acute pancreatitis.

Authors:  Péter Hegyi; Stephen Pandol; Viktória Venglovecz; Zoltán Rakonczay
Journal:  Gut       Date:  2010-09-28       Impact factor: 23.059

3.  Effects of octreotide on acute necrotizing pancreatitis in rabbits.

Authors:  László Czakó; Péter Hegyi; Tamás Takács; Csaba Góg; András Farkas; Yvette Mándy; Ilona Sz Varga; László Tiszlavicz; János Lonovics
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

Review 4.  Physiology and pathophysiology of bicarbonate secretion by pancreatic duct epithelium.

Authors:  Hiroshi Ishiguro; Akiko Yamamoto; Miyuki Nakakuki; Lanjuan Yi; Mariko Ishiguro; Makoto Yamaguchi; Shiho Kondo; Yuka Mochimaru
Journal:  Nagoya J Med Sci       Date:  2012-02       Impact factor: 1.131

5.  Reduced Pancreatic Exocrine Function and Organellar Disarray in a Canine Model of Acute Pancreatitis.

Authors:  Yuepeng Jin; Yongyu Bai; Qiang Li; Pravin Avinash Bhugul; Xince Huang; Lewei Liu; Liangliang Pan; Haizhen Ni; Bicheng Chen; Hongwei Sun; Qiyu Zhang; Michael Hehir; Mengtao Zhou
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

6.  Ductal Mucus Obstruction and Reduced Fluid Secretion Are Early Defects in Chronic Pancreatitis.

Authors:  Anita Balázs; Zsolt Balla; Balázs Kui; József Maléth; Zoltán Rakonczay; Julia Duerr; Zhe Zhou-Suckow; Jolanthe Schatterny; Matthias Sendler; Julia Mayerle; Jens-P Kühn; László Tiszlavicz; Marcus A Mall; Peter Hegyi
Journal:  Front Physiol       Date:  2018-05-29       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.